Issue 4/2012
Content (19 Articles)
Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin
Yan Liang, Marilyn Johnston, Jack Hirsh, Guillaume Pare, Chunjian Li, Shamir Mehta, Koon K. Teo, Debi Sloane, Qilong Yi, Jun Zhu, John W. Eikelboom
Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital
Kimberly L. Carter, Michael B. Streiff, Patricia A. Ross, Jessica C. Wellman, Michelle L. Thomas, Peggy S. Kraus, Kenneth M. Shermock
Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study
Huan Huang, Jonathan R. Korn, Rajiv Mallick, Mark Friedman, Christine Nichols, Joseph Menzin
How to prevent bleeding events in on- and off-pump coronary artery bypass patients exposed to clopidogrel preoperatively
Mate Petricevic, Bojan Biocina, Sanja Konosic, Ivan Burcar
Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies
Kuangguo Zhou, Ruizhi Zhao, Zhe Geng, Lijun Jiang, Yang Cao, Danmei Xu, Yin Liu, Liang Huang, Jianfeng Zhou
Free fatty acids inhibit TM–EPCR expression through JNK pathway: an implication for the development of the prothrombotic state in metabolic syndrome
Wanmu Xie, Zhenguo Zhai, Yuanhua Yang, Tuguang Kuang, Chen Wang
Lymphocyte subset characterization in patients with early clinical presentation of coronary heart disease
Natale Daniele Brunetti, Carmine D’Antuono, Michele Rana, Girolamo D’Arienzo, Luisa De Gennaro, Matteo Di Biase
Bleeding risk factors associated with argatroban therapy in the critically ill
Bruce Doepker, Kari L. Mount, Lindsay J. Ryder, Anthony T. Gerlach, Claire V. Murphy, Gary S. Philips
Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary intervention
Yiding Li, Bee-Choo Tai, Winnie Sia, Qian-Hui Phua, Mark A. Richards, Adrian Low, Koo-Hui Chan, Swee-Guan Teo, Tiong-Beng Sim, Chi-Hang Lee, Matthew T. Roe, Tiong-Cheng Yeo, Huay-Cheem Tan, Mark Y. Chan
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up
Carlo Giansante, Nicola Fiotti, Nicola Altamura, Paola Pitacco, Lara Consoloni, Sabino Scardi, Carmine Mazzone, Gabriele Grassi, Claudio Pandullo, Andrea Di Lenarda
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard–Soulier syndrome
Antonio Girolami, Silvia Vettore, Fabrizio Vianello, Giulia Berti de Marinis, Fabrizio Fabris
Thromboprophylaxis in major knee and hip replacement surgery: a review
Gonzalo Eymin, Amir K. Jaffer
Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplasty
Yohei Yukizawa, Yutaka Inaba, Shin-ichiro Watanabe, Satoshi Yajima, Naomi Kobayashi, Takashi Ishida, Naoyuki Iwamoto, Choe Hyonmin, Mashio Nakamura, Tomoyuki Saito
Stenotic coexistence among coronary, renal and extracrainal arteries in Chinese patients
Yuqiang Fang, Xian Shu, Chenming Yang, Xukai Wang, Hongyong Wang, Chunjiang Fu, Weibin Shi, Ye Zhang, Qiao Chen, Li Yang, Chunyu Zeng
Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin
Jihane Abou Rahal, Rim S. Ishak, Zaher K. Otrock, Abdul-Ghani Kibbi, Ali T. Taher
Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study
Eric L. Wallace, Susan S. Smyth
Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician
Connie N. Hess, Richard C. Becker, John H. Alexander, Renato D. Lopes